Abstract: The present invention relate to a method for authenticating a low performance device, and more particularly, to a device authenticating method, in which a low performance device such as a smart meter of a smart grid is authenticated in a matrix operation instead of an exponential operation through a homomorphic hash function (HHF) of a non-square matrix M, so that the amount of operations required for authenticating the device can be reduced and the device can be safely authenticated even without a separate certificate authority.

Abstract: The present invention relates to radar and antenna technique, and more particularly, to a radar apparatus and an antenna apparatus having antenna configuration of arranging a plurality of array antennas capable of concentrating antenna gain on a direction for sensing.

Abstract: A lens movement control method and a lens movement control apparatus of a camera module for preventing allophone of a Voice Coil Actuator (VCA) are provided. The lens movement control method of a camera module includes switching the camera module from a camera operation mode to a camera stop mode, generating a control signal for removing the occurrence of VCA allophone in the camera stop mode, moving a lens to a VCA allophone removal location based on the generated control signal, and powering-off the camera module to move the lens moved to the VCA allophone removal location to a bottom surface of the lens.

Abstract: A lens movement control method and a lens movement control apparatus of a camera module for preventing allophone of a Voice Coil Actuator (VCA) are provided. The lens movement control method of a camera module includes switching the camera module from a camera operation mode to a camera stop mode, generating a control signal for removing the occurrence of VCA allophone in the camera stop mode, moving a lens to a VCA allophone removal location based on the generated control signal, and powering-off the camera module to move the lens moved to the VCA allophone removal location to a bottom surface of the lens.

Abstract: Disclosed are an apparatus and a method for identifying a plurality of tire pressure sensor modules. Data wirelessly transmitted from the tire pressure sensor modules are received by using a signal cable connected between a wheel speed sensor module and a control module. The control module identifies the pressure sensor modules mounted on vehicle tires according to the intensities of received signals.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal

Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.

Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.

Abstract: The high-speed pattern storing and matching method includes dividing pattern data having a defined rule into parts having a defined length, tabulating and storing input position sequence information of the divided parts of the pattern data and information about the pattern data subsequent to the corresponding divided part of the pattern data, dividing input pattern data into parts having a defined length, independently searching the divided parts of the input pattern data, and determining whether the pattern data input according to each input position sequence are matched to the pattern data having the defined rules, thereby enabling high-speed pattern matching in real time and storing repeating words in one address of memories to enhance the memory efficiency.

Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.

Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.